These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 10359590)
1. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Penuel E; Martin GS Mol Biol Cell; 1999 Jun; 10(6):1693-703. PubMed ID: 10359590 [TBL] [Abstract][Full Text] [Related]
2. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells. Nguyen KT; Wang WJ; Chan JL; Wang LH Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940 [TBL] [Abstract][Full Text] [Related]
3. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene. Agazie Y; Ischenko I; Hayman M Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699 [TBL] [Abstract][Full Text] [Related]
5. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines. Maeda N; Fu W; Ortin A; de las Heras M; Fan H J Virol; 2005 Apr; 79(7):4440-50. PubMed ID: 15767444 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
7. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975 [TBL] [Abstract][Full Text] [Related]
8. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways. Fukazawa H; Uehara Y Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668 [TBL] [Abstract][Full Text] [Related]
9. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]
10. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Grammer TC; Blenis J Oncogene; 1997 Apr; 14(14):1635-42. PubMed ID: 9135064 [TBL] [Abstract][Full Text] [Related]
11. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Sarker KP; Lee KY Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659 [TBL] [Abstract][Full Text] [Related]
12. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Akagi T; Murata K; Shishido T; Hanafusa H Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282 [TBL] [Abstract][Full Text] [Related]
13. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340 [TBL] [Abstract][Full Text] [Related]
14. Downstream effectors of oncogenic ras in multiple myeloma cells. Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321 [TBL] [Abstract][Full Text] [Related]
16. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927 [TBL] [Abstract][Full Text] [Related]
17. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Liu Y; Fanburg BL Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541 [TBL] [Abstract][Full Text] [Related]
18. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948 [TBL] [Abstract][Full Text] [Related]